FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases [2]

Hepatology

Volumn 43, Issue 2, 2006, Pages 373-374

  Castera, Laurent ^a   Foucher, Juliette ^a   Bertet, Julien ^a   Couzigou, Patrice ^a   De Ledinghen, Victor ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE;

ADULT; AGED; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MONITORING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS CARRIER;

BIOPSY; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; SENSITIVITY AND SPECIFICITY;

EID: 33644525960     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21019     Document Type: Letter

References (6)

1. Colletta C, Smirne C, Fabris C, Toniutto P, Rapetti R, Minisini R, et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. HEPATOLOGY 2005;42:838-845.
2. Ghany MG, Doo E. Assessment ot liver fibrosis: palpate, poke or pulse? HEPATOLOGY 2005;42:759-761.
3. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup F, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-350.
4. Ziol M, Handra-Luca A, Kettaneh A, Christidis G, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. HEPATOLOGY 2005;41:48-54.
5. Foucher J, Gastera L, Bernard PH, Adhoute X, Lahanie D, Berret J, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan® in a prospective study of 2114 examination. Eur J Gastroenterol Hepatol 2006: in press.
6. Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004;3:8.